Clinical Trial Update: A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update of insulin degludec injection in subjects with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN